News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis C treatment news

Show

From To
Hepatitis C treatment
HCV protease inhibitors likely to work for co-infected patients previously treated for HCV

Previous treatment with pegylated interferon and ribavirin will not reduce the effectiveness of hepatitis C protease inhibitors in HIV-positive patients, US investigators report in the September 15th edition

Published
30 August 2010
By
Michael Carter
Hepatitis C treatment
Thai activists call for treatment for hepatitis C for people with HIV

Treating co-infection of HIV and hepatitis C (HCV) in Thailand makes sound economic sense, Noah Methany argues in a policy paper published by the Thai AIDS Treatment

Published
13 August 2010
By
Carole Leach-Lemens
New and experimental hepatitis C treatment
Vertex releases results of phase III study of telaprevir in hepatitis C

Vertex Pharmaceuticals today announced results from the Phase 3 ILLUMINATE study, which was designed to evaluate whether there was any benefit to extending therapy from 24 to 48 weeks in people whose hepatitis C virus (HCV) was undetectable at weeks 4 and 12 of treatment (extended rapid viral response or eRVR).

Published
10 August 2010
From
Business Wire
Hepatitis C treatment
Does nevirapine improve hepatitis C treatment outcomes in HIV/HCV co-infected individuals?

HIV/hepatitis C (HCV) co-infected people who included nevirapine (Viramune) in their antiretroviral therapy (ART) regimen were more likely to achieve sustained response to interferon-based therapy for chronic hepatitis

Published
21 July 2010
By
Liz Highleyman
Hepatitis C treatment
Depression overlooked in patients with hepatitis C; compromising HCV therapy

Researchers from Denmark, Sweden, Norway and Finland (the NORDynamIC project group) have observed that depressive symptoms in patients with hepatitis C virus (HCV) infection are commonly overlooked in routine clinical interviews, and that treatment-induced depression compromises the outcome of HCV therapy.

Published
20 July 2010
From
Eurekalert Medicine & Health
Hepatitis C treatment
Medivir reports 24-week interim phase 2b results of TMC-435 in treatment-naive patients with HCV genotype 1

Published
12 July 2010
From
The Medical News
Hepatitis C treatment
Insulin resistance impairs response to hepatitis C therapy for patients co-infected with HIV

Insulin resistance is associated with an impaired response to hepatitis C therapy for HIV-positive patients, Spanish investigators report in the online edition of the Journal

Published
02 July 2010
By
Michael Carter
Hepatitis and HIV
IL28B gene variation predicts response to hepatitis C treatment: will it change treatment of co-infection?

Variations in the IL28B gene that have recently been linked to better treatment response among people with chronic hepatitis C virus (HCV) infection may also

Published
01 March 2010
By
Liz Highleyman
Hepatitis C treatment
Successful hepatitis C treatment reduces HIV disease progression and non-liver-related mortality

HIV/HCV-co-infected people who achieve a sustained virological response to interferon-based therapy not only reduce their risk of death due to liver disease, but also experience

Published
22 February 2010
By
Liz Highleyman
Hepatitis and HIV
Genetic test predicts who will respond to hepatitis C treatment

Researchers report in Nature that they have identified a gene that predicts response to treatment for hepatitis C with pegylated interferon and ribavirin. “Advanced knowledge

Published
17 August 2009
By
Michael Carter
← Prev1...102103104105106Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.